Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Total Liabilities (2023 - 2025)

Profound Medical has reported Total Liabilities over the past 3 years, most recently at $11.0 million for Q4 2025.

  • Quarterly results put Total Liabilities at $11.0 million for Q4 2025, up 12.53% from a year ago — trailing twelve months through Dec 2025 was $11.0 million (up 12.53% YoY), and the annual figure for FY2025 was $11.0 million, up 12.53%.
  • Total Liabilities for Q4 2025 was $11.0 million at Profound Medical, up from $10.2 million in the prior quarter.
  • Over the last five years, Total Liabilities for PROF hit a ceiling of $12.7 million in Q4 2023 and a floor of -$45.5 million in Q1 2024.
  • Median Total Liabilities over the past 3 years was $10.1 million (2025), compared with a mean of -$5.7 million.
  • Biggest five-year swings in Total Liabilities: decreased 22.93% in 2024 and later skyrocketed 133.08% in 2025.
  • Profound Medical's Total Liabilities stood at $12.7 million in 2023, then decreased by 22.93% to $9.8 million in 2024, then rose by 12.53% to $11.0 million in 2025.
  • The last three reported values for Total Liabilities were $11.0 million (Q4 2025), $10.2 million (Q3 2025), and $10.4 million (Q2 2025) per Business Quant data.